摘要
目的探讨麝香保心丸联合倍他乐克治疗冠心病不稳定性心绞痛的临床疗效。方法 106例冠心病不稳定性心绞痛患者随机平均分为两组,对照组采用常规调脂、口服硝酸酯类、抗凝、抗血小板类等药物进行治疗,观察组在对照组药物治疗的基础上同时服用麝香保心丸联合倍他乐克进行治疗。观察治疗3个月后两组心绞痛及心电图改善情况。结果观察组总有效率为96.2%,对照组为50.9%,观察组患者治疗后心绞痛发作次数、治疗总有效率和心电图等改善情况均明显优于对照组,差异有统计学意义(P<0.05)。两组治疗后均无严重不良反应。结论麝香保心丸联合倍他乐克治疗冠心病不稳定性心绞痛疗效显著且安全性高。
Objective To explore the clinical effect of Shexiangbaoxin Pill and Betaloc in the treatment of coronary heart disease unstable angina pectoris. Methods 106 cases of patients with coronary heart disease unstable angina pectoris were randomly and equally divided into two groups. The control group was treated by conventional drugs of regulating lipid, oral nitrates, anticoagulation, antiplatelet and so on, the observation group was treated by Shexiangbaoxin Pill and Betaloc on the basis of the treatment of the control group. 3 months after treatment, the improvements of angina pectoris and electrocardiogram of the two groups were observed. Results The total effective rate of the observation group was 96.2%, and that of the control group was 50.9%; after treatment, the frequency of angina pectoris attack, total effective rate and the improvement of electrocardiogram of the observation group were superior to those of the control group, the differences were statistically significant, P〈0.05. And no severe adverse reactions occurred in both groups after treatment. Conclusion Shexiangbaoxin Pill and Betaloc have notable curative effect in the treatment of coronary heart disease unstable angina pectoris with high safety.
出处
《中外医疗》
2014年第22期3-4,共2页
China & Foreign Medical Treatment
关键词
麝香保心丸
倍他乐克
冠心病
Shexiangbaoxin Pill
Betaloc
Coronary heart disease
